Items without sitelinks

Showing below up to 50 results in range #751 to #800.

751. manner of articulation (Q21715)
752. phonetics and speech science (Q21714)
753. phonetics (Q21713)
754. articulatory apparatus (Q21712)
755. speech organ (Q21711)
756. subdivision of mouth (Q21710)
757. lip (Q21709)
758. lip disease (Q21708)
759. cheilosis (Q21707)
760. disorder of vitamin and non-protein cofactor absorption and transport (Q21706)
761. vitamin deficiency (Q21705)
762. vitamin B deficiency (Q21704)
763. adjuvant (Q21698)
764. immunologic adjuvant (Q21697)
765. L-Malate + NAD⁺ ⇌ Oxaloacetate + NADH + H⁺ (Q21691)
766. hydroxy acid (Q21690)
767. alpha hydroxy acid (Q21689)
768. DL-malic acid (Q21688)
769. L-malic acid (Q21687)
770. Fumarate + H₂O ⇌ L-Malate (Q21686)
771. ubiquinol-10 (Q21685)
772. fumaric acid (Q21684)
773. involuntary movement (Q21683)
774. Huntington's disease-like syndrome (Q21682)
775. choreatic disease (Q21681)
776. HTT (Q21680)
777. trinucleotide repeat expansion (Q21679)
778. repeat expansion disorders (Q21678)
779. trinucleotide repeat disorder (Q21677)
780. genetic dementia (Q21676)
781. neurodegenerative disease with dementia (Q21675)
782. genetic neurodegenerative disease with dementia (Q21674)
783. eye degenerative disease (Q21673)
784. nervous system heredodegenerative disease (Q21672)
785. Huntington disease and related disorders (Q21671)
786. Huntington's disease (Q21670)
787. lipid metabolism disorder (Q21668)
788. familial hyperlipidemia (Q21667)
789. quinone catabolic process (Q21666)
790. ubiquinone catabolic process (Q21665)
791. ubiquinone biosynthetic process via 3,4-dihydroxy-5-polyprenylbenzoate (Q21664)
792. ubiquinone biosynthetic process via 2-polyprenylphenol (Q21663)
793. quinone binding (Q21662)
794. ubiquinone binding (Q21661)
795. coenzymes (Q21660)
796. ubiquinone (Q21659)
797. phenolic lipid (Q21658)
798. alkylhydroquinone (Q21657)
799. ubidecarenone (Q21656)
800. Succinate + ubiquinone (Q) ⇌ Fumarate + ubiquinol (QH₂) (Q21655)